

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | behavioral response to nicotine (GO:0035095) | 5.24088178 |
| 2 | kynurenine metabolic process (GO:0070189) | 4.90381849 |
| 3 | tryptophan catabolic process (GO:0006569) | 4.84837776 |
| 4 | indole-containing compound catabolic process (GO:0042436) | 4.84837776 |
| 5 | indolalkylamine catabolic process (GO:0046218) | 4.84837776 |
| 6 | indolalkylamine metabolic process (GO:0006586) | 4.81257919 |
| 7 | tryptophan metabolic process (GO:0006568) | 4.61599988 |
| 8 | cellular ketone body metabolic process (GO:0046950) | 4.17743682 |
| 9 | cilium or flagellum-dependent cell motility (GO:0001539) | 4.07287386 |
| 10 | sperm motility (GO:0030317) | 4.00497163 |
| 11 | negative regulation of systemic arterial blood pressure (GO:0003085) | 3.89115831 |
| 12 | primary amino compound metabolic process (GO:1901160) | 3.88032022 |
| 13 | serotonin metabolic process (GO:0042428) | 3.83056877 |
| 14 | indole-containing compound metabolic process (GO:0042430) | 3.79686405 |
| 15 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.79468017 |
| 16 | detection of light stimulus involved in visual perception (GO:0050908) | 3.79468017 |
| 17 | gamma-aminobutyric acid transport (GO:0015812) | 3.77354351 |
| 18 | ketone body metabolic process (GO:1902224) | 3.76850290 |
| 19 | protein polyglutamylation (GO:0018095) | 3.76080810 |
| 20 | NAD biosynthetic process (GO:0009435) | 3.72236018 |
| 21 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.69378244 |
| 22 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.66186207 |
| 23 | fucose catabolic process (GO:0019317) | 3.56756703 |
| 24 | L-fucose metabolic process (GO:0042354) | 3.56756703 |
| 25 | L-fucose catabolic process (GO:0042355) | 3.56756703 |
| 26 | regulation of sarcomere organization (GO:0060297) | 3.47174676 |
| 27 | reflex (GO:0060004) | 3.43936579 |
| 28 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.41848896 |
| 29 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.41848896 |
| 30 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.41848896 |
| 31 | acrosome reaction (GO:0007340) | 3.39872044 |
| 32 | response to pheromone (GO:0019236) | 3.38465481 |
| 33 | multicellular organism reproduction (GO:0032504) | 3.38151728 |
| 34 | sulfation (GO:0051923) | 3.37877777 |
| 35 | signal peptide processing (GO:0006465) | 3.36042888 |
| 36 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.33374415 |
| 37 | cellular biogenic amine catabolic process (GO:0042402) | 3.30290440 |
| 38 | amine catabolic process (GO:0009310) | 3.30290440 |
| 39 | epithelial cilium movement (GO:0003351) | 3.30031745 |
| 40 | regulation of hippo signaling (GO:0035330) | 3.26089975 |
| 41 | regulation of gene silencing by RNA (GO:0060966) | 3.25374616 |
| 42 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.25374616 |
| 43 | regulation of gene silencing by miRNA (GO:0060964) | 3.25374616 |
| 44 | establishment of protein localization to Golgi (GO:0072600) | 3.24025331 |
| 45 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.22245620 |
| 46 | membrane depolarization during action potential (GO:0086010) | 3.12158307 |
| 47 | cilium movement (GO:0003341) | 3.11891280 |
| 48 | regulation of female gonad development (GO:2000194) | 3.10957282 |
| 49 | regulation of action potential (GO:0098900) | 3.08975472 |
| 50 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.02967622 |
| 51 | protein K48-linked deubiquitination (GO:0071108) | 3.00222197 |
| 52 | response to misfolded protein (GO:0051788) | 2.94323108 |
| 53 | spinal cord motor neuron differentiation (GO:0021522) | 2.93630745 |
| 54 | negative regulation of multicellular organism growth (GO:0040015) | 2.88022309 |
| 55 | photoreceptor cell maintenance (GO:0045494) | 2.87245931 |
| 56 | calcium ion-dependent exocytosis (GO:0017156) | 2.86317029 |
| 57 | axonemal dynein complex assembly (GO:0070286) | 2.86240309 |
| 58 | nonmotile primary cilium assembly (GO:0035058) | 2.86089998 |
| 59 | neuronal action potential (GO:0019228) | 2.82224806 |
| 60 | cAMP catabolic process (GO:0006198) | 2.80536975 |
| 61 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.80424547 |
| 62 | negative regulation of mast cell activation (GO:0033004) | 2.79368883 |
| 63 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.79008878 |
| 64 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.78454622 |
| 65 | transmission of nerve impulse (GO:0019226) | 2.76589766 |
| 66 | regulation of cilium movement (GO:0003352) | 2.76086126 |
| 67 | axoneme assembly (GO:0035082) | 2.75812869 |
| 68 | behavioral response to ethanol (GO:0048149) | 2.75739868 |
| 69 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.72796130 |
| 70 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.72796130 |
| 71 | cilium organization (GO:0044782) | 2.70371986 |
| 72 | protein K11-linked deubiquitination (GO:0035871) | 2.68285757 |
| 73 | protein K63-linked deubiquitination (GO:0070536) | 2.65496964 |
| 74 | cilium assembly (GO:0042384) | 2.63777450 |
| 75 | appendage development (GO:0048736) | 2.63581734 |
| 76 | limb development (GO:0060173) | 2.63581734 |
| 77 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.62974950 |
| 78 | multicellular organismal movement (GO:0050879) | 2.62432699 |
| 79 | musculoskeletal movement (GO:0050881) | 2.62432699 |
| 80 | cell proliferation in forebrain (GO:0021846) | 2.60331060 |
| 81 | flavonoid metabolic process (GO:0009812) | 2.59314792 |
| 82 | synaptic transmission, glutamatergic (GO:0035249) | 2.58769370 |
| 83 | positive regulation of fatty acid oxidation (GO:0046321) | 2.58600966 |
| 84 | aromatic amino acid family catabolic process (GO:0009074) | 2.57256931 |
| 85 | peristalsis (GO:0030432) | 2.56176394 |
| 86 | protein localization to cilium (GO:0061512) | 2.55417257 |
| 87 | regulation of establishment of cell polarity (GO:2000114) | 2.55299560 |
| 88 | snRNA transcription (GO:0009301) | 2.55170735 |
| 89 | opioid receptor signaling pathway (GO:0038003) | 2.54863570 |
| 90 | interkinetic nuclear migration (GO:0022027) | 2.54164499 |
| 91 | benzene-containing compound metabolic process (GO:0042537) | 2.53630675 |
| 92 | neural tube formation (GO:0001841) | 2.53315561 |
| 93 | microtubule severing (GO:0051013) | 2.53286842 |
| 94 | glutamate receptor signaling pathway (GO:0007215) | 2.52466078 |
| 95 | cyclic nucleotide catabolic process (GO:0009214) | 2.51959158 |
| 96 | male meiosis I (GO:0007141) | 2.51900146 |
| 97 | aromatic amino acid family metabolic process (GO:0009072) | 2.51267439 |
| 98 | postsynaptic membrane organization (GO:0001941) | 2.49771826 |
| 99 | startle response (GO:0001964) | 2.49677123 |
| 100 | DNA methylation involved in gamete generation (GO:0043046) | 2.48318603 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.14729499 |
| 2 | VDR_22108803_ChIP-Seq_LS180_Human | 3.07343986 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.92069200 |
| 4 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.86547870 |
| 5 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.46448780 |
| 6 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.46222345 |
| 7 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.40980137 |
| 8 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.39078731 |
| 9 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.23081527 |
| 10 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.11231535 |
| 11 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.02993170 |
| 12 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.94377968 |
| 13 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.82493252 |
| 14 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.80069180 |
| 15 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.77724188 |
| 16 | P300_19829295_ChIP-Seq_ESCs_Human | 1.76276838 |
| 17 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.75611555 |
| 18 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.74834775 |
| 19 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.74834775 |
| 20 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.69669832 |
| 21 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.69303873 |
| 22 | FUS_26573619_Chip-Seq_HEK293_Human | 1.68636756 |
| 23 | STAT3_23295773_ChIP-Seq_U87_Human | 1.67463325 |
| 24 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.65885020 |
| 25 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.65661876 |
| 26 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.63492898 |
| 27 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.62347334 |
| 28 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.60902823 |
| 29 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.59576117 |
| 30 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.59112291 |
| 31 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.58952232 |
| 32 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.57627768 |
| 33 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.57522808 |
| 34 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.53630018 |
| 35 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.52533759 |
| 36 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.50326878 |
| 37 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.49443806 |
| 38 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.49443806 |
| 39 | TCF4_23295773_ChIP-Seq_U87_Human | 1.47570499 |
| 40 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.46139752 |
| 41 | AR_25329375_ChIP-Seq_VCAP_Human | 1.45626836 |
| 42 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.44098240 |
| 43 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.42339739 |
| 44 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.41896827 |
| 45 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.39093582 |
| 46 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.36198541 |
| 47 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.35678875 |
| 48 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.35410229 |
| 49 | EWS_26573619_Chip-Seq_HEK293_Human | 1.35339049 |
| 50 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.33463673 |
| 51 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.32031930 |
| 52 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.31500378 |
| 53 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.31278397 |
| 54 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.29653320 |
| 55 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.26116478 |
| 56 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.25882052 |
| 57 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.24426315 |
| 58 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.24221182 |
| 59 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.21722188 |
| 60 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.18638598 |
| 61 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.17567091 |
| 62 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.17469072 |
| 63 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.17027064 |
| 64 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.16676937 |
| 65 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.16186896 |
| 66 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.15655056 |
| 67 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.15544139 |
| 68 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.15379453 |
| 69 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.14499559 |
| 70 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.14499559 |
| 71 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.12697652 |
| 72 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.11585993 |
| 73 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.11585993 |
| 74 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.11518475 |
| 75 | KDM2B_26808549_Chip-Seq_REH_Human | 1.11237272 |
| 76 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.10452008 |
| 77 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.09669308 |
| 78 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09407291 |
| 79 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.09061401 |
| 80 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.07464409 |
| 81 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.07258606 |
| 82 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 1.05815025 |
| 83 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.05650656 |
| 84 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.05550567 |
| 85 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05538541 |
| 86 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.05246129 |
| 87 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.05200251 |
| 88 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.04802124 |
| 89 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.03770215 |
| 90 | TP53_16413492_ChIP-PET_HCT116_Human | 1.03490342 |
| 91 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.01842867 |
| 92 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.01517203 |
| 93 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.01106517 |
| 94 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.98563795 |
| 95 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.98027384 |
| 96 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.97135456 |
| 97 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.96062561 |
| 98 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.96048146 |
| 99 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.94530479 |
| 100 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.94352523 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 4.42772409 |
| 2 | MP0003195_calcinosis | 2.67859643 |
| 3 | MP0005410_abnormal_fertilization | 2.62658409 |
| 4 | MP0001968_abnormal_touch/_nociception | 2.50064816 |
| 5 | MP0009745_abnormal_behavioral_response | 2.47571424 |
| 6 | MP0009046_muscle_twitch | 2.41534688 |
| 7 | MP0005551_abnormal_eye_electrophysiolog | 2.40450867 |
| 8 | MP0003646_muscle_fatigue | 2.35312209 |
| 9 | MP0005377_hearing/vestibular/ear_phenot | 2.30550975 |
| 10 | MP0003878_abnormal_ear_physiology | 2.30550975 |
| 11 | MP0001501_abnormal_sleep_pattern | 2.26069628 |
| 12 | MP0001485_abnormal_pinna_reflex | 2.18680862 |
| 13 | MP0002736_abnormal_nociception_after | 2.08060840 |
| 14 | MP0006292_abnormal_olfactory_placode | 2.06832244 |
| 15 | MP0002735_abnormal_chemical_nociception | 2.01284342 |
| 16 | MP0008872_abnormal_physiological_respon | 1.94594211 |
| 17 | MP0002272_abnormal_nervous_system | 1.93408793 |
| 18 | MP0008877_abnormal_DNA_methylation | 1.88980145 |
| 19 | MP0003136_yellow_coat_color | 1.77761359 |
| 20 | MP0001486_abnormal_startle_reflex | 1.76167017 |
| 21 | MP0002064_seizures | 1.75076964 |
| 22 | MP0004142_abnormal_muscle_tone | 1.72460608 |
| 23 | MP0002733_abnormal_thermal_nociception | 1.68435315 |
| 24 | MP0005646_abnormal_pituitary_gland | 1.67064289 |
| 25 | MP0002138_abnormal_hepatobiliary_system | 1.66765658 |
| 26 | MP0005670_abnormal_white_adipose | 1.65688903 |
| 27 | MP0002572_abnormal_emotion/affect_behav | 1.65601243 |
| 28 | MP0005083_abnormal_biliary_tract | 1.64271363 |
| 29 | MP0001970_abnormal_pain_threshold | 1.64036721 |
| 30 | MP0006276_abnormal_autonomic_nervous | 1.61871893 |
| 31 | MP0004742_abnormal_vestibular_system | 1.55480021 |
| 32 | MP0000631_abnormal_neuroendocrine_gland | 1.55477818 |
| 33 | MP0001905_abnormal_dopamine_level | 1.54889394 |
| 34 | MP0000372_irregular_coat_pigmentation | 1.52145423 |
| 35 | MP0003635_abnormal_synaptic_transmissio | 1.51530559 |
| 36 | MP0002557_abnormal_social/conspecific_i | 1.49885386 |
| 37 | MP0002822_catalepsy | 1.49397741 |
| 38 | MP0002653_abnormal_ependyma_morphology | 1.47262202 |
| 39 | MP0001440_abnormal_grooming_behavior | 1.44997950 |
| 40 | MP0002067_abnormal_sensory_capabilities | 1.44318500 |
| 41 | MP0003698_abnormal_male_reproductive | 1.43589678 |
| 42 | MP0004885_abnormal_endolymph | 1.42866653 |
| 43 | MP0002928_abnormal_bile_duct | 1.41219736 |
| 44 | MP0004043_abnormal_pH_regulation | 1.39968709 |
| 45 | MP0005171_absent_coat_pigmentation | 1.39910575 |
| 46 | MP0002102_abnormal_ear_morphology | 1.36423694 |
| 47 | MP0005174_abnormal_tail_pigmentation | 1.36216715 |
| 48 | MP0005423_abnormal_somatic_nervous | 1.35964363 |
| 49 | MP0005253_abnormal_eye_physiology | 1.35388076 |
| 50 | MP0004145_abnormal_muscle_electrophysio | 1.34732763 |
| 51 | MP0001986_abnormal_taste_sensitivity | 1.34003868 |
| 52 | MP0005645_abnormal_hypothalamus_physiol | 1.33525935 |
| 53 | MP0004133_heterotaxia | 1.33419901 |
| 54 | MP0003787_abnormal_imprinting | 1.30673659 |
| 55 | MP0002734_abnormal_mechanical_nocicepti | 1.27194886 |
| 56 | MP0002837_dystrophic_cardiac_calcinosis | 1.25787404 |
| 57 | MP0002063_abnormal_learning/memory/cond | 1.20288503 |
| 58 | MP0003252_abnormal_bile_duct | 1.19336971 |
| 59 | MP0002876_abnormal_thyroid_physiology | 1.17509609 |
| 60 | MP0000026_abnormal_inner_ear | 1.16490926 |
| 61 | MP0002160_abnormal_reproductive_system | 1.15475517 |
| 62 | MP0004130_abnormal_muscle_cell | 1.15377265 |
| 63 | MP0001963_abnormal_hearing_physiology | 1.14042306 |
| 64 | MP0005386_behavior/neurological_phenoty | 1.13969914 |
| 65 | MP0004924_abnormal_behavior | 1.13969914 |
| 66 | MP0003879_abnormal_hair_cell | 1.13855292 |
| 67 | MP0004147_increased_porphyrin_level | 1.13606085 |
| 68 | MP0001348_abnormal_lacrimal_gland | 1.11540949 |
| 69 | MP0003880_abnormal_central_pattern | 1.11338486 |
| 70 | MP0001929_abnormal_gametogenesis | 1.09656296 |
| 71 | MP0001984_abnormal_olfaction | 1.08666421 |
| 72 | MP0000427_abnormal_hair_cycle | 1.07931887 |
| 73 | MP0002938_white_spotting | 1.07622850 |
| 74 | MP0005084_abnormal_gallbladder_morpholo | 1.04400279 |
| 75 | MP0003718_maternal_effect | 1.03140877 |
| 76 | MP0002638_abnormal_pupillary_reflex | 1.00948200 |
| 77 | MP0005389_reproductive_system_phenotype | 0.99299620 |
| 78 | MP0006072_abnormal_retinal_apoptosis | 0.98007870 |
| 79 | MP0003011_delayed_dark_adaptation | 0.97844519 |
| 80 | MP0002229_neurodegeneration | 0.95826540 |
| 81 | MP0000230_abnormal_systemic_arterial | 0.95434688 |
| 82 | MP0002163_abnormal_gland_morphology | 0.95432206 |
| 83 | MP0005195_abnormal_posterior_eye | 0.94852163 |
| 84 | MP0003119_abnormal_digestive_system | 0.93315098 |
| 85 | MP0002752_abnormal_somatic_nervous | 0.92734197 |
| 86 | MP0005379_endocrine/exocrine_gland_phen | 0.90543398 |
| 87 | MP0000049_abnormal_middle_ear | 0.88779566 |
| 88 | MP0000955_abnormal_spinal_cord | 0.88717266 |
| 89 | MP0002210_abnormal_sex_determination | 0.87058836 |
| 90 | MP0010386_abnormal_urinary_bladder | 0.86975026 |
| 91 | MP0002882_abnormal_neuron_morphology | 0.81890132 |
| 92 | MP0000653_abnormal_sex_gland | 0.80304314 |
| 93 | MP0002234_abnormal_pharynx_morphology | 0.78448935 |
| 94 | MP0005310_abnormal_salivary_gland | 0.78335275 |
| 95 | MP0004085_abnormal_heartbeat | 0.78246915 |
| 96 | MP0002184_abnormal_innervation | 0.77924374 |
| 97 | MP0009053_abnormal_anal_canal | 0.77757557 |
| 98 | MP0003137_abnormal_impulse_conducting | 0.77220910 |
| 99 | MP0008961_abnormal_basal_metabolism | 0.77056397 |
| 100 | MP0003633_abnormal_nervous_system | 0.76560601 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Genetic anticipation (HP:0003743) | 6.07213640 |
| 2 | Progressive cerebellar ataxia (HP:0002073) | 5.09976996 |
| 3 | Pancreatic cysts (HP:0001737) | 4.47596478 |
| 4 | Pancreatic fibrosis (HP:0100732) | 4.22466062 |
| 5 | True hermaphroditism (HP:0010459) | 3.94121334 |
| 6 | Gaze-evoked nystagmus (HP:0000640) | 3.79855875 |
| 7 | Abnormality of midbrain morphology (HP:0002418) | 3.66469281 |
| 8 | Molar tooth sign on MRI (HP:0002419) | 3.66469281 |
| 9 | Nephronophthisis (HP:0000090) | 3.64752631 |
| 10 | Attenuation of retinal blood vessels (HP:0007843) | 3.64666027 |
| 11 | Hyperventilation (HP:0002883) | 3.60446575 |
| 12 | Chronic hepatic failure (HP:0100626) | 3.59343256 |
| 13 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.48013350 |
| 14 | Absent/shortened dynein arms (HP:0200106) | 3.48013350 |
| 15 | Severe visual impairment (HP:0001141) | 3.42238054 |
| 16 | Abolished electroretinogram (ERG) (HP:0000550) | 3.38364323 |
| 17 | Pendular nystagmus (HP:0012043) | 3.33408333 |
| 18 | Congenital stationary night blindness (HP:0007642) | 3.22710196 |
| 19 | Decreased central vision (HP:0007663) | 3.19293807 |
| 20 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.13412298 |
| 21 | Abnormality of the renal medulla (HP:0100957) | 3.08563847 |
| 22 | Cystic liver disease (HP:0006706) | 3.00489553 |
| 23 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.92136211 |
| 24 | Abnormality of the renal cortex (HP:0011035) | 2.92098243 |
| 25 | Congenital sensorineural hearing impairment (HP:0008527) | 2.90068080 |
| 26 | Sclerocornea (HP:0000647) | 2.87195030 |
| 27 | Keratoconus (HP:0000563) | 2.85334783 |
| 28 | Increased corneal curvature (HP:0100692) | 2.85334783 |
| 29 | Protruding tongue (HP:0010808) | 2.83446235 |
| 30 | Type II lissencephaly (HP:0007260) | 2.81730719 |
| 31 | Abnormal ciliary motility (HP:0012262) | 2.80207725 |
| 32 | Abnormal drinking behavior (HP:0030082) | 2.68488172 |
| 33 | Polydipsia (HP:0001959) | 2.68488172 |
| 34 | Medial flaring of the eyebrow (HP:0010747) | 2.67540060 |
| 35 | Clumsiness (HP:0002312) | 2.65231046 |
| 36 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.58797996 |
| 37 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.58797996 |
| 38 | Tubular atrophy (HP:0000092) | 2.58458439 |
| 39 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.53586861 |
| 40 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.52264109 |
| 41 | Abnormality of binocular vision (HP:0011514) | 2.48116085 |
| 42 | Diplopia (HP:0000651) | 2.48116085 |
| 43 | Abnormality of alanine metabolism (HP:0010916) | 2.40805716 |
| 44 | Hyperalaninemia (HP:0003348) | 2.40805716 |
| 45 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.40805716 |
| 46 | Febrile seizures (HP:0002373) | 2.38088525 |
| 47 | Inability to walk (HP:0002540) | 2.37341749 |
| 48 | Retinal dysplasia (HP:0007973) | 2.36110561 |
| 49 | Decreased circulating renin level (HP:0003351) | 2.34337564 |
| 50 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.33997281 |
| 51 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.32177155 |
| 52 | Anencephaly (HP:0002323) | 2.26126668 |
| 53 | Congenital hepatic fibrosis (HP:0002612) | 2.25614742 |
| 54 | Cerebellar dysplasia (HP:0007033) | 2.25274400 |
| 55 | Impaired smooth pursuit (HP:0007772) | 2.23521614 |
| 56 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.16830432 |
| 57 | Furrowed tongue (HP:0000221) | 2.16663939 |
| 58 | Focal seizures (HP:0007359) | 2.15205884 |
| 59 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.12989617 |
| 60 | Dialeptic seizures (HP:0011146) | 2.11111105 |
| 61 | Gait imbalance (HP:0002141) | 2.10920131 |
| 62 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.09952524 |
| 63 | Congenital, generalized hypertrichosis (HP:0004540) | 2.08581324 |
| 64 | Polyuria (HP:0000103) | 2.07023790 |
| 65 | Hypoplastic ischia (HP:0003175) | 2.05746168 |
| 66 | Male pseudohermaphroditism (HP:0000037) | 2.05584190 |
| 67 | Hypoplasia of the pons (HP:0012110) | 2.04336307 |
| 68 | Absence seizures (HP:0002121) | 2.00978755 |
| 69 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.00689041 |
| 70 | Congenital primary aphakia (HP:0007707) | 1.99949961 |
| 71 | Large for gestational age (HP:0001520) | 1.98540465 |
| 72 | Abnormality of macular pigmentation (HP:0008002) | 1.97742242 |
| 73 | Hemiparesis (HP:0001269) | 1.97565354 |
| 74 | Broad-based gait (HP:0002136) | 1.96947146 |
| 75 | Concave nail (HP:0001598) | 1.96535906 |
| 76 | Chorioretinal atrophy (HP:0000533) | 1.96360053 |
| 77 | Agitation (HP:0000713) | 1.92720011 |
| 78 | Genital tract atresia (HP:0001827) | 1.92163297 |
| 79 | Dysmetric saccades (HP:0000641) | 1.88448289 |
| 80 | Postaxial foot polydactyly (HP:0001830) | 1.87767778 |
| 81 | Abnormality of the pons (HP:0007361) | 1.86905224 |
| 82 | Postural instability (HP:0002172) | 1.86897467 |
| 83 | Vaginal atresia (HP:0000148) | 1.85539321 |
| 84 | Retinitis pigmentosa (HP:0000510) | 1.84983708 |
| 85 | Lissencephaly (HP:0001339) | 1.84589914 |
| 86 | Hemiplegia (HP:0002301) | 1.82732129 |
| 87 | Focal motor seizures (HP:0011153) | 1.82705028 |
| 88 | Small hand (HP:0200055) | 1.81655682 |
| 89 | Absent speech (HP:0001344) | 1.79698543 |
| 90 | Hypothermia (HP:0002045) | 1.79092441 |
| 91 | Nephrogenic diabetes insipidus (HP:0009806) | 1.78639796 |
| 92 | Optic nerve hypoplasia (HP:0000609) | 1.78557721 |
| 93 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.77836208 |
| 94 | Abnormal urine output (HP:0012590) | 1.75261601 |
| 95 | Macular degeneration (HP:0000608) | 1.74896106 |
| 96 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.73893342 |
| 97 | Oligodactyly (hands) (HP:0001180) | 1.73647043 |
| 98 | Progressive inability to walk (HP:0002505) | 1.72854061 |
| 99 | Abnormality of the ischium (HP:0003174) | 1.72736394 |
| 100 | Patellar aplasia (HP:0006443) | 1.72420980 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 8.55512536 |
| 2 | ADRBK2 | 3.58035305 |
| 3 | BMPR1B | 2.91415146 |
| 4 | INSRR | 2.91315674 |
| 5 | ACVR1B | 2.87449782 |
| 6 | GRK1 | 2.59941379 |
| 7 | CASK | 2.32768205 |
| 8 | ZAK | 2.02654838 |
| 9 | SIK2 | 1.77675872 |
| 10 | WNK3 | 1.75022792 |
| 11 | TAOK3 | 1.74860254 |
| 12 | WNK4 | 1.70982131 |
| 13 | MAP3K4 | 1.69844550 |
| 14 | OXSR1 | 1.68370461 |
| 15 | TLK1 | 1.67512294 |
| 16 | PINK1 | 1.63164438 |
| 17 | ADRBK1 | 1.48641801 |
| 18 | MAP4K2 | 1.47641251 |
| 19 | DAPK2 | 1.47186625 |
| 20 | NUAK1 | 1.46771937 |
| 21 | MAPK13 | 1.46450554 |
| 22 | PLK4 | 1.35444569 |
| 23 | PTK2B | 1.32458866 |
| 24 | NTRK3 | 1.28679120 |
| 25 | PRKCG | 1.24384440 |
| 26 | STK38L | 1.20003724 |
| 27 | TXK | 1.17915458 |
| 28 | MKNK2 | 1.15619353 |
| 29 | STK39 | 1.11933186 |
| 30 | MAP2K7 | 1.11479294 |
| 31 | TNIK | 1.10241031 |
| 32 | PNCK | 1.10081576 |
| 33 | STK38 | 1.07318598 |
| 34 | PRKCE | 1.07033155 |
| 35 | TNK2 | 1.01193654 |
| 36 | CDK19 | 0.99941453 |
| 37 | PAK3 | 0.88524037 |
| 38 | MAPK15 | 0.86782076 |
| 39 | CAMK1G | 0.86421518 |
| 40 | PRKCH | 0.83137106 |
| 41 | PLK2 | 0.82593518 |
| 42 | MARK1 | 0.80901119 |
| 43 | NTRK2 | 0.76295496 |
| 44 | AKT3 | 0.75175566 |
| 45 | TEC | 0.74809321 |
| 46 | PKN1 | 0.72867838 |
| 47 | TGFBR1 | 0.71084699 |
| 48 | CAMK1D | 0.70933040 |
| 49 | PIK3CG | 0.70337299 |
| 50 | DYRK2 | 0.68724852 |
| 51 | CAMKK2 | 0.68297208 |
| 52 | CAMK1 | 0.64094674 |
| 53 | PRKCQ | 0.61450619 |
| 54 | CAMK2A | 0.59980158 |
| 55 | TIE1 | 0.59342254 |
| 56 | PIK3CA | 0.59184229 |
| 57 | SGK2 | 0.57740528 |
| 58 | EPHA3 | 0.56344967 |
| 59 | PRKAA2 | 0.54492535 |
| 60 | STK11 | 0.53570246 |
| 61 | VRK1 | 0.52886526 |
| 62 | IKBKB | 0.52777570 |
| 63 | WNK1 | 0.51890947 |
| 64 | RPS6KA6 | 0.51527843 |
| 65 | PRKAA1 | 0.51184613 |
| 66 | MAP3K9 | 0.50961551 |
| 67 | STK16 | 0.50610539 |
| 68 | DDR2 | 0.50012978 |
| 69 | MAP3K7 | 0.49994738 |
| 70 | PRKCZ | 0.49265872 |
| 71 | ITK | 0.49051337 |
| 72 | CHUK | 0.48689090 |
| 73 | GRK7 | 0.48089053 |
| 74 | PRKACA | 0.48019814 |
| 75 | SGK223 | 0.48007148 |
| 76 | SGK494 | 0.48007148 |
| 77 | MAP2K6 | 0.47600261 |
| 78 | PRKCI | 0.46641386 |
| 79 | MAP2K4 | 0.45020653 |
| 80 | CAMK4 | 0.44788118 |
| 81 | STK3 | 0.43906671 |
| 82 | ERBB2 | 0.43852206 |
| 83 | SGK1 | 0.42442593 |
| 84 | IRAK1 | 0.42371383 |
| 85 | PRKCA | 0.41226623 |
| 86 | RPS6KA5 | 0.40454698 |
| 87 | MARK3 | 0.39389853 |
| 88 | GRK5 | 0.38743561 |
| 89 | PRKG1 | 0.38355809 |
| 90 | BLK | 0.37157448 |
| 91 | CSNK1A1 | 0.36990089 |
| 92 | TYRO3 | 0.36221207 |
| 93 | CSNK1G2 | 0.35205798 |
| 94 | FER | 0.34889372 |
| 95 | TAF1 | 0.34351927 |
| 96 | CSNK1D | 0.33228625 |
| 97 | OBSCN | 0.29206344 |
| 98 | PRKCB | 0.28841173 |
| 99 | NEK2 | 0.28549664 |
| 100 | PRKD2 | 0.28420023 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.11153128 |
| 2 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.66952643 |
| 3 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.61349440 |
| 4 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.42691516 |
| 5 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.40624818 |
| 6 | Phototransduction_Homo sapiens_hsa04744 | 2.35720063 |
| 7 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.22798317 |
| 8 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.21946172 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.16907008 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.16091821 |
| 11 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.11672459 |
| 12 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.07718058 |
| 13 | Taste transduction_Homo sapiens_hsa04742 | 2.04054689 |
| 14 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.03784369 |
| 15 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.86327149 |
| 16 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.83019433 |
| 17 | Olfactory transduction_Homo sapiens_hsa04740 | 1.77055044 |
| 18 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.76430454 |
| 19 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.76010771 |
| 20 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.74814040 |
| 21 | ABC transporters_Homo sapiens_hsa02010 | 1.73586741 |
| 22 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.71995390 |
| 23 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.69242622 |
| 24 | GABAergic synapse_Homo sapiens_hsa04727 | 1.67969071 |
| 25 | Circadian entrainment_Homo sapiens_hsa04713 | 1.52503126 |
| 26 | Homologous recombination_Homo sapiens_hsa03440 | 1.51489207 |
| 27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.48222604 |
| 28 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.44935721 |
| 29 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.40113811 |
| 30 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.39750228 |
| 31 | Insulin secretion_Homo sapiens_hsa04911 | 1.32235071 |
| 32 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.25376111 |
| 33 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.25126907 |
| 34 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.24448628 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.16173839 |
| 36 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.16141369 |
| 37 | Retinol metabolism_Homo sapiens_hsa00830 | 1.14540617 |
| 38 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.07200366 |
| 39 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.06781828 |
| 40 | Salivary secretion_Homo sapiens_hsa04970 | 1.06219210 |
| 41 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.05974071 |
| 42 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.04918932 |
| 43 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.00902674 |
| 44 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.94548277 |
| 45 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.93856364 |
| 46 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.93264852 |
| 47 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.91479388 |
| 48 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.90961741 |
| 49 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.90073035 |
| 50 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.87950633 |
| 51 | RNA polymerase_Homo sapiens_hsa03020 | 0.86693009 |
| 52 | Basal transcription factors_Homo sapiens_hsa03022 | 0.86626457 |
| 53 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.86220781 |
| 54 | Cocaine addiction_Homo sapiens_hsa05030 | 0.86053510 |
| 55 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.84542381 |
| 56 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.84274736 |
| 57 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.83348306 |
| 58 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.82170327 |
| 59 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.82167954 |
| 60 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.76971225 |
| 61 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.75766772 |
| 62 | Histidine metabolism_Homo sapiens_hsa00340 | 0.75382855 |
| 63 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.75157474 |
| 64 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.74443651 |
| 65 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.73375330 |
| 66 | Long-term depression_Homo sapiens_hsa04730 | 0.72229530 |
| 67 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.64251793 |
| 68 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.64024662 |
| 69 | Peroxisome_Homo sapiens_hsa04146 | 0.62455385 |
| 70 | Renin secretion_Homo sapiens_hsa04924 | 0.61875376 |
| 71 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.60895436 |
| 72 | Huntingtons disease_Homo sapiens_hsa05016 | 0.59583731 |
| 73 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.59239665 |
| 74 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.57035916 |
| 75 | Alcoholism_Homo sapiens_hsa05034 | 0.54769581 |
| 76 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.53159101 |
| 77 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.52457286 |
| 78 | Lysine degradation_Homo sapiens_hsa00310 | 0.52358099 |
| 79 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.51028809 |
| 80 | Sulfur relay system_Homo sapiens_hsa04122 | 0.49983268 |
| 81 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.49969022 |
| 82 | Mineral absorption_Homo sapiens_hsa04978 | 0.48858062 |
| 83 | Melanoma_Homo sapiens_hsa05218 | 0.46098827 |
| 84 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.46000925 |
| 85 | Parkinsons disease_Homo sapiens_hsa05012 | 0.43582527 |
| 86 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.41106227 |
| 87 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39682755 |
| 88 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.39297338 |
| 89 | Alzheimers disease_Homo sapiens_hsa05010 | 0.38801561 |
| 90 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.37947917 |
| 91 | Purine metabolism_Homo sapiens_hsa00230 | 0.37436771 |
| 92 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.36687842 |
| 93 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.35524890 |
| 94 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.34540918 |
| 95 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.33903713 |
| 96 | Metabolic pathways_Homo sapiens_hsa01100 | 0.32574641 |
| 97 | Bile secretion_Homo sapiens_hsa04976 | 0.32299933 |
| 98 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.31897062 |
| 99 | Circadian rhythm_Homo sapiens_hsa04710 | 0.30853253 |
| 100 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.30252429 |

